Oxford Finance LLC
Venture debtAlexandria · Seed–Late Stage · 45 people tracked
Find your way into Oxford Finance LLC
451 people in our graph share verified history with the Oxford Finance LLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Oxford Finance's real estate team focuses on facility-based healthcare lending across acute, post-acute, and specialty segments in the United States. It offers financing for working capital, acquisitions, refinancing, cash-out recaps, and property transitions, serving both operators and investor-owners of single assets or portfolios. Products include working capital revolvers, senior term loans, Term Loan B and second lien, mezzanine loans, and equity or structured equity, backed by full capital markets capability. Loan sizes range from $5MM to $125MM with tenors up to five years, initial interest-only periods, and amortization up to 25 years.
Source: firm website, verified Sep 15, 2026.
Team · 45 people
from the firm's website & public directoriesWhat they invest in
from 9 of 9 portfolio companiesBiotech ×6Healthtech ×2AI & Machine Learning ×1Creator Economy ×1E-commerce ×1EdTech ×1Media & Entertainment ×1Medical Devices ×1
HQs:United States×7Canada×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2020 · 12012 · 12 dated
Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.
BiotechEmeryville, US
Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in
Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesRTW Investments L.P.Westlake BioPartners
Amino Labs produces hands-on biotechnology experiment kits designed to teach genetic engineering and bacterial transformation to beginners in educational and hobbyist settings.
BiotechEdTechSouthern Alberta, CA
Julie Legault(CEO)inJustin Pahara(Biotechnology Expert)
Co-investorsSOSVThe E14 FundAccelAspect VenturesCRV (Charles River Ventures)Highland Capital Partners+1 more
Narvii.com is an independent information website that publishes articles about digital platforms, online communities, and popular apps.
Creator EconomyMedia & EntertainmentSocial
Alexander Smith(Editor-in-Chief)
Co-investorsBantam GroupHighland Capital PartnersTRANSFORMATION CAPITAL
Fynd provides a commerce platform with AI agents for sales and support, letting brands build websites, sell on marketplaces (Amazon, Myntra, Noon, Trendyol), run wholesale operations, modernise retail stores, and manage orders, payments, and logistics.
AI & Machine LearningE-commerceRetail TechSaaSSeattle, US
Farooq Adam(Founder)inNicolas Nezhat(President)
Co-investorsRocketship.vcVelocityTrinity CapitalVenture Catalysts
Inhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.
BiotechLa Jolla, US
Mark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)
BoardJudith Li(Director)
Co-investorsLAVLilly Asia VenturesRA Capital
BiotechBridgewater, US
Navneet Puri(Executive Officer)
Co-investorsH.I.G. CapitalH.I.G. HealthBridge Partners
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Co-investorsCapital Midwest FundFrazier Life SciencesLongitude CapitalRA CapitalVivo Capital
Tarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.
BiotechPhiladelphia, US
David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)
BoardRichard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Derek Ferguson(Director)
Co-investorsForesite CapitalMVM Life Science PartnersQuaker BioVentures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsKyverna TherapeuticsNASDAQ: KYTX
Portfolio news
latest coverage across their companiesInhibrx · ng.investing.com · Aug 21, 2026
Frequently asked questions
- How many investments has Oxford Finance LLC made?
- Oxford Finance LLC has 9 tracked investments, 1 of which have exited.
- What stage does Oxford Finance LLC invest at?
- Oxford Finance LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Oxford Finance LLC's typical check size?
- Oxford Finance LLC typically writes checks of $5M – $125M.
- What sectors does Oxford Finance LLC focus on?
- Oxford Finance LLC focuses on Biotech, Healthtech, Medical Devices, PropTech.
- Where is Oxford Finance LLC located?
- Oxford Finance LLC is headquartered in Alexandria, US.
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
INP Capital is a global investment firm that invests across the full company life cycle, from early stage to pre-IPO, seeking to identify and back emerging technology companies as they scale toward unicorn status.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.

























































